Imatinib | High-Quality Pharmaceutical Reference Standard
Imatinib is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and other malignancies with BCR-ABL or c-KIT mutations. It inhibits BCR-ABL and other tyrosine kinases, reducing tumor cell proliferation. Imatinib API is manufactured under GMP-compliant conditions and is suitable for oral solid dosage formulations, including tablets.
Imatinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 18
